Vimarsana
Biggest News Aggregation in the World

Filip Van News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Filip Van. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Filip Van Today - Breaking & Trending Today

Study highlights ubiquinol's menopause benefits - Vimarsana News

Study highlights ubiquinol's menopause benefits

Kaneka Nutrients Europe is eyeing the menopause market segment for its ubiquinol form of coenzyme Q10, with a new consumer research study showing that 80% of participants reporting that ubiquinol could alleviate menopausal symptoms.

Care Property Invest / : Invitation à l'assemblée générale ordinaire des actionnaires 2024 (version anglaise) - Vimarsana News

Care Property Invest / : Invitation à l'assemblée générale ordinaire des actionnaires 2024 (version anglaise)

Free translation. The Dutch version will prevail. Invitation Annual General Meeting 25 April 2024 ...

Natural Products Industry News Briefs: Kaneka, BGG, FrieslandCampina & More - Vimarsana News

Natural Products Industry News Briefs: Kaneka, BGG, FrieslandCampina & More

Read up on all the latest news in the natural products industry, including sustainability initiatives, supply chain updates, and more.

Steering the microbiome for improved poultry gut health - Vimarsana News

Steering the microbiome for improved poultry gut health

Adjusting the feed formula for optimal digestion of protein may help prevent dysbiosis and support intestinal health in birds, finds a paper in the June 2023 edition of Animal Nutrition.

RINVOQ速 (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis - Vimarsana News

RINVOQ速 (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.